Relevant Publications

  1. Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 2004 Nov; 50(11):3450-7. PMID:15529378.
  2. Kremers HM, Crowson CS, Gabriel SE. Rochester epidemiology project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am. 2004 Nov; 30(4):819-34. PMID:15488695.
  3. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis-a population-based cohort study. Arthritis Rheum. 2005 Feb; 52(2):402-11. PMID:15693010.
  4. Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE. The risk of congestive heart failure in rheumatoid arthritis-a population-based study over 46 years. Arthritis Rheum. 2005 Feb; 52(2):412-20. PMID:15692992.
  5. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005 Mar; 52(3):722-32. PMID:15751097.
  6. Crowson CS, Nicola PJ, Maradit Kremers H, O’Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum. 2005 Oct; 52(10):3039-44. PMID:16200583.
  7. Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum. 2006 Jan; 54(1):60-7.
  8. Liang KP, Gabriel SE. Autoantibodies: Innocent Bystander or Key Player in Immunosenescence and Atherosclerosis? J Rheumatol 2006;34(6):1203-1207.
  9. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Jacobsen SJ, Roger VL, Gabriel SE. Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis. Ann Rheum Dis. 2007 Jan; 66(1):76-80. Epub 2006 Jul 03. PMID:16818462. PMCID:1798392. DOI:10.1136/ard.2006.053710.
  10. Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2007 Mar; 56(3):820-30. PMID:17330254.
  11. Aubry MC, Maradit-Kremers H, Reinalda MS, Crowson CS, Edwards WD, Gabriel SE. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol. 2007 May; 34(5):937-42. PMID:17361987.
  12. Gonzalez A, Maradit Kremers H, Crowson CS, Ballman KV, Roger VL, Jacobsen SJ, O’Fallon WM, Gabriel SE. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis. 2008 Jan; 67(1):64-9. Epub 2007 May 21. PMID:17517756. DOI:10.1136/ard.2006.059980.
  13. Gabriel SE. Do antirheumatic drugs increase the risk of acute myocardial infarction? [Practice Point Commentary] Nat Clin Pract Rheum 2007;3(1):12-13.
  14. Gabriel SE. Heart Disease in Rheumatoid Arthritis: Changing the Paradigm of Systemic Inflammatory Disorders. [Keynote address] J Rheumatol 2007;34(1):220-223.
  15. Maradit Kremer H, Crowson CS, Gabriel SE. Cardiovascular risk factors in rheumatoid arthritis. Current Medical Literature-Rheumatology. 2008; 27(1):1-12. 146.
  16. Gabriel SE. Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis. Am J Med (RA Supplement) 2008;121(10A):S9-S14.
  17. Gabriel SE. Tumor Necrosis Factor Inhibition: A Part of the Solution or a Part of the Problem of Heart Failure in Rheumatoid Arthritis. Arthritis Rheum 2008; 58:637-640.
  18. Kremers HM, Crowson CS, Therneau TM, Roger VL, Gabriel SE. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum. 2008 Aug; 58(8):2268-74. PMID:18668561. PMCID:2929699. DOI:10.1002/art.23650.

*Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 2008 Sep; 58(9):2603-11. PMID:18759286. PMCID:2631416. DOI:10.1002/art.23798.

  1. Liang KP, Kremers HM, Crowson CS, Snyder MR, Therneau TM, Roger VL, Gabriel SE. Autoantibodies and the risk of cardiovascular events. J Rheumatol. 2009 Nov; 36(11):2462-9. Epub 2009 Oct 15. PMID:19833748. PMCID:2837072. DOI:10.3899/jrheum.090188.
  2. *Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis. 2010 Jul; 69(7):1310-4. Epub 2009 Oct 23. PMID:19854708. PMCID:2890039. DOI:10.1136/ard.2009.122374.
  3. *Liang KP, Myasoedova E, Crowson CS, Davis JM, Roger VL, Karon BL, Borgeson DD, Therneau TM, Rodeheffer RJ, Gabriel SE. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis. 2010 Sep; 69(9):1665-70. Epub 2010 May 24. PMID:20498217. PMCID:2920362. DOI:10.1136/ard.2009.124362.
  4. Crowson CS. Rheumatoid arthritis and heart disease: the chicken and the egg? J Intern Med. 2010 Dec; 268(6):552-4. Epub 2010 Nov 05. PMID:21054586. DOI:10.1111/j.1365-2796.2010.02296.x.
  5. Gabriel SE. Heart Disease and Rheumatoid Arthritis: Understanding the Risks. [Manuscript from a presentation at 2009 “Advances in Targeted Therapies”]. Ann Rheum Dis 2010;69:i61-i64.
  6. Kremers HM, Myasoedova E, Crowson CS, Savova G, Gabriel SE, Matteson EL. The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases. Rheumatology (Oxford). 2011 Jan; 50(1):6-15. Epub 2010 Jul 13. PMID:20627969. PMCID:3716332. DOI:10.1093/rheumatology/keq199.
  7. Crowson CS, Myasoedova E, Davis JM 3rd, Matteson EL, Roger VL, Therneau TM, Fitz-Gibbon P, Rodeheffer RJ, Gabriel SE. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol. 2011 Jan; 38(1):29-35. Epub 2010 Oct 15. PMID:20952464. PMCID:3014403. DOI:10.3899/jrheum.100346.
  8. Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011 Mar; 70(3):482-7. Epub 2011 Jan 07.
  9. Kitas GD, Gabriel SE. Cardiovascular Disease in Rheumatoid Arthritis: State of the Art and Future Perspectives. Ann Rheum Dis 2011;70:8-14.
  10. Symmons D, Gabriel SE. Epidemiology of cardiovascular disease co-morbidity in rheumatic disease, with a focus on rheumatoid arthritis and systemic lupus erythematosus. Nat Rev Rheumatol 2011 July;(7): 399-408 PMID: 21629241.
  11. Crowson CS, Gabriel SE. Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Ann Rheum Dis. 2011 May; 70(5):719-21. Epub 2011 Feb 22. PMID:21345812. PMCID:3907170. DOI:10.1136/ard.2010.145482.
  12. Crowson CS, Myasoedova E, Davis JM 3rd, Roger VL, Karon BL, Borgeson D, Rodeheffer RJ, Therneau TM, Gabriel SE. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken). 2011 May; 63(5):729-34. PMID:21225672. PMCID:3091972. DOI:10.1002/acr.20425.
  13. Myasoedova E, Crowson CS, Nicola PJ, Maradit-Kremers H, Davis JM 3rd, Roger VL, Therneau TM, Gabriel SE. The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol. 2011 Aug; 38(8):1601-6. Epub 2011 May 15. PMID:21572155. PMCID:3337549. DOI:10.3899/jrheum.100979.
  14. Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Roger VL, Matteson EL, Gabriel SE. A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis. Arthritis Rheum. 2011 Jun; 63(6):1497-506. PMID:21384332. PMCID:3106129. DOI:10.1002/art.30323.
  15. Bacani AK, Gabriel SE, Crowson CS, Heit JA, Matteson EL. Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum. 2012 Jan; 64(1):53-61. PMID:21905005. PMCID:3474372. DOI:10.1002/art.33322.
  16. McCoy SS, Crowson CS, Gabriel SE, Matteson EL. Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol. 2012 May; 39(5):954-8. Epub 2012 Feb 15. PMID:22337246. PMCID:3518421. DOI:10.3899/jrheum.111076.
  17. Gabriel SE, Crowson CS. Risk factors for cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol. 2012 Mar; 24(2):171-6. PMID:22249350. DOI:10.1097/BOR.0b013e32834ff2fd.
  18. Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol. 2012 Aug 1; 110(3):420-4. Epub 2012 Apr 20. PMID:22521305. PMCID:3398213. DOI:10.1016/j.amjcard.2012.03.044.
  19. McCoy SS, Crowson CS, Maradit-Kremers H, Therneau TM, Roger VL, Matteson EL, Gabriel SE. Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J Rheumatol. 2013 May; 40(5):605-10. Epub 2013 Feb 15. PMID:23418388. PMCID:3895921. DOI:10.3899/jrheum.120941.
  20. Akkara Veetil BM, Myasoedova E, Matteson EL, Gabriel SE, Crowson CS. Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study. J Rheumatol. 2013 Jul; 40(7):1082-8. Epub 2013 May 01. PMID:23637326. PMCID:3891914. DOI:10.3899/jrheum.121302.
  21. Myasoedova E, Davis JM 3rd, Crowson CS, Roger VL, Karon BL, Borgeson DD, Therneau TM, Matteson EL, Rodeheffer RJ, Gabriel SE. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum. 2013 Jul; 65(7):1713-8. PMID:23553738. PMCID:3914147. DOI:10.1002/art.37949.
  22. Fine NM, Crowson CS, Lin G, Oh JK, Villarraga HR, Gabriel SE. Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography. Ann Rheum Dis. 2013 Jul 19. PMID:23873875. PMCID:3895498. DOI:10.1136/annrheumdis-2013-203314.
  23. Crowson CS, Liao KP, Davis JM 3rd, Solomon DH, Matteson EL, Knutson KL, Hlatky MA, Gabriel SE. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013 Oct; 166(4):622-628.e1. Epub 2013 Aug 29. PMID:24093840. PMCID:3890244. DOI:10.1016/j.ahj.2013.07.010.
  24. Myasoedova E, Gabriel SE, Green AB, Matteson EL, Crowson CS. Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study. Arthritis Care Res (Hoboken). 2013 Oct; 65(10):1592-9. PMID:23592565. PMCID:3788038. DOI:10.1002/acr.22029.
  25. Crowson CS, Therneau TM, Davis JM 3rd, Roger VL, Matteson EL, Gabriel SE. Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis. Arthritis Rheum. 2013 Oct; 65(10):2562-6. PMID:23818136. PMCID:3966134. DOI:10.1002/art.38071.
  26. Hickson LJ, Crowson CS, Gabriel SE, McCarthy JT, Matteson EL. Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis. 2014 Feb; 63(2):206-13. Epub 2013 Oct 4 PMID:24100126. PMCID:3944015. DOI:10.1053/j.ajkd.2013.08.010.